Roles of HIV-1 Env variable regions in viral neutralization and vaccine development
- PMID: 18045110
- DOI: 10.2174/157016207782418470
Roles of HIV-1 Env variable regions in viral neutralization and vaccine development
Abstract
A major focus of HIV-1 vaccine development has been directed towards a limited number of broadly conserved epitopes in the Envelope (Env) proteins that are sensitive neutralization targets in many primary isolates. However, evidence suggests that these epitopes are poorly immunogenic; similar antibodies are rarely produced by infected subjects, nor are they induced by various immunogens designed to express these epitopes. On the other hand, the major variable domains of Env are highly immunogenic; antibodies against these regions are common in sera of infected patients and easily generated upon immunization. Although these epitopes are extremely sensitive neutralization targets in some laboratory strains and primary isolates, the neutralization range of antibodies against these sites is limited. This review describes potent neutralization epitopes located in the variable regions of Env and discusses the bases for the limited neutralization breadth of antibodies against these targets. Strategies are discussed for using available information to design immunogens capable of exploiting the potential of these regions as vaccine targets.
Similar articles
-
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15. J Virol. 2016. PMID: 26763999 Free PMC article.
-
Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.J Virol. 2018 Feb 12;92(5):e01779-17. doi: 10.1128/JVI.01779-17. Print 2018 Mar 1. J Virol. 2018. PMID: 29237828 Free PMC article.
-
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.J Virol. 2018 Feb 12;92(5):e01796-17. doi: 10.1128/JVI.01796-17. Print 2018 Mar 1. J Virol. 2018. PMID: 29237847 Free PMC article.
-
Structure-based vaccine design in HIV: blind men and the elephant?Curr Pharm Des. 2010;16(33):3744-53. doi: 10.2174/138161210794079173. Curr Pharm Des. 2010. PMID: 21128885 Free PMC article. Review.
-
Antibody epitope exposure and neutralization of HIV-1.Curr Pharm Des. 2010;16(33):3729-43. doi: 10.2174/138161210794079182. Curr Pharm Des. 2010. PMID: 21128886 Review.
Cited by
-
Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.Curr Drug Targets. 2010 Mar;11(3):264-78. doi: 10.2174/138945010790711914. Curr Drug Targets. 2010. PMID: 20210752 Free PMC article. Review.
-
Functional implications of the binding mode of a human conformation-dependent V2 monoclonal antibody against HIV.J Virol. 2014 Apr;88(8):4100-12. doi: 10.1128/JVI.03153-13. Epub 2014 Jan 29. J Virol. 2014. PMID: 24478429 Free PMC article.
-
Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.Antiviral Res. 2011 Jun;90(3):195-9. doi: 10.1016/j.antiviral.2011.03.186. Epub 2011 Apr 1. Antiviral Res. 2011. PMID: 21459115 Free PMC article.
-
Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer.Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20148-53. doi: 10.1073/pnas.1104840108. Epub 2011 Nov 29. Proc Natl Acad Sci U S A. 2011. PMID: 22128330 Free PMC article.
-
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape.PLoS Pathog. 2012;8(5):e1002721. doi: 10.1371/journal.ppat.1002721. Epub 2012 May 31. PLoS Pathog. 2012. PMID: 22693447 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
